Pajk, B. Et Al. 2008. Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: Findings from the EORTC 10001 randomized phase II trial. BREAST , vol.17, no.2 , 180-185.

Pajk, B., Cufer, T., Canney, P., Ellis, P., Cameron, D., Blot, E., ... Vermorken, J.(2008). Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: Findings from the EORTC 10001 randomized phase II trial. BREAST , vol.17, no.2, 180-185.

Pajk, Bojana Et Al. "Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: Findings from the EORTC 10001 randomized phase II trial," BREAST , vol.17, no.2, 180-185, 2008

Pajk, Bojana Et Al. "Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: Findings from the EORTC 10001 randomized phase II trial." BREAST , vol.17, no.2, pp.180-185, 2008

Pajk, B. Et Al. (2008) . "Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: Findings from the EORTC 10001 randomized phase II trial." BREAST , vol.17, no.2, pp.180-185.

@article{article, author={Bojana Pajk Et Al. }, title={Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: Findings from the EORTC 10001 randomized phase II trial}, journal={BREAST}, year=2008, pages={180-185} }